Literature DB >> 24568684

Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England.

V D Hope1, F Ncube1, J V Parry2, M Hickman3.   

Abstract

People who inject drugs (PWID) are vulnerable to infections and injuries at injection sites. The factors associated with reporting symptoms of these, seeking related advice, and hospital admission are examined. PWID were recruited in Birmingham, Bristol and Leeds using respondent-driven sampling (N = 855). During the preceding year, 48% reported having redness, swelling and tenderness (RST), 19% an abscess, and 10% an open wound at an injection site. Overall, 54% reported ⩾1 symptoms, with 45% of these seeking medical advice (main sources emergency departments and General Practitioners). Advice was often sought ⩾5 days after the symptom first appeared (44% of those seeking advice about an abscess, 45% about an open wound, and 35% for RST); the majority received antibiotics. Overall, 9·5% reported hospital admission during the preceding year. Ever being diagnosed with septicaemia and endocarditis were reported by 8·8% and 2·9%, respectively. Interventions are needed to reduce morbidity, healthcare burden and delays in accessing treatment.

Entities:  

Mesh:

Year:  2014        PMID: 24568684      PMCID: PMC9206814          DOI: 10.1017/S0950268814000284

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  31 in total

1.  Chronic illicit drug use, health services utilization and the cost of medical care.

Authors:  M T French; K A McGeary; D D Chitwood; C B McCoy
Journal:  Soc Sci Med       Date:  2000-06       Impact factor: 4.634

2.  Physical injecting sites among injecting drug users in Sydney, Australia.

Authors:  S Darke; J Ross; S Kaye
Journal:  Drug Alcohol Depend       Date:  2001-03-01       Impact factor: 4.492

3.  Injecting-related injury and disease among clients of a supervised injecting facility.

Authors:  Allison M Salmon; Robyn Dwyer; Marianne Jauncey; Ingrid van Beek; Libby Topp; Lisa Maher
Journal:  Drug Alcohol Depend       Date:  2009-01-23       Impact factor: 4.492

4.  Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.

Authors:  R Dwyer; L Topp; L Maher; R Power; M Hellard; N Walsh; M Jauncey; A Conroy; J Lewis; C Aitken
Journal:  Drug Alcohol Depend       Date:  2008-11-14       Impact factor: 4.492

5.  Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital.

Authors:  Michael Marks; Emily Pollock; Margaret Armstrong; Stephen Morris-Jones; Michael Kidd; Philip Gothard; Mahdad Noursadeghi; Justin F Doherty
Journal:  J Infect       Date:  2012-10-12       Impact factor: 6.072

6.  The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

Authors:  Katy M E Turner; Sharon Hutchinson; Peter Vickerman; Vivian Hope; Noel Craine; Norah Palmateer; Margaret May; Avril Taylor; Daniela De Angelis; Sheila Cameron; John Parry; Margaret Lyons; David Goldberg; Elizabeth Allen; Matthew Hickman
Journal:  Addiction       Date:  2011-08-24       Impact factor: 6.526

7.  Type and location of injection drug use-related soft tissue infections predict hospitalization.

Authors:  Traci A Takahashi; Joseph O Merrill; Edward J Boyko; Katharine A Bradley
Journal:  J Urban Health       Date:  2003-03       Impact factor: 3.671

Review 8.  The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later.

Authors:  C E Cherubin; J D Sapira
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

9.  Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.

Authors:  Ross J Harris; Mary Ramsay; Vivian D Hope; Lisa Brant; Matthew Hickman; Graham R Foster; Daniela De Angelis
Journal:  Eur J Public Health       Date:  2011-06-26       Impact factor: 3.367

10.  Skin and soft tissue infections and vascular disease among drug users, England.

Authors:  Charles Irish; Roy Maxwell; Mark Dancox; Paul Brown; Caroline Trotter; Julia Verne; Mary Shaw
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more
  15 in total

1.  A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States.

Authors:  Jenny E Ozga; Jennifer L Syvertsen; John A Zweifler; Robin A Pollini
Journal:  Health Soc Care Community       Date:  2021-09-01

2.  Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study.

Authors:  Joshua A Barocas; Golnaz Eftekhari Yazdi; Alexandra Savinkina; Shayla Nolen; Caroline Savitzky; Jeffrey H Samet; Honora Englander; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors:  V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal:  Epidemiol Infect       Date:  2014-04-08       Impact factor: 4.434

4.  Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Authors:  Raagini Jawa; Michael D Stein; Bradley Anderson; Jane M Liebschutz; Catherine Stewart; Kristina T Phillips; Joshua A Barocas
Journal:  Int J Drug Policy       Date:  2021-03-18

5.  Community Wound Care Program Within a Syringe Exchange Program: Chicago, 2018-2019.

Authors:  Michael Huyck; Stockton Mayer; Sarah Messmer; Charles Yingling
Journal:  Am J Public Health       Date:  2020-06-18       Impact factor: 11.561

6.  Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.

Authors:  Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka
Journal:  Open Forum Infect Dis       Date:  2016-07-26       Impact factor: 3.835

7.  'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.

Authors:  M Harris; R Brathwaite; Catherine R McGowan; D Ciccarone; G Gilchrist; M McCusker; K O'Brien; J Dunn; J Scott; V Hope
Journal:  Harm Reduct J       Date:  2018-05-08

8.  Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK.

Authors:  Talen Wright; Vivian Hope; Daniel Ciccarone; Dan Lewer; Jenny Scott; Magdalena Harris
Journal:  PLoS One       Date:  2020-07-14       Impact factor: 3.752

9.  Clonal expansion of community-associated meticillin-resistant Staphylococcus aureus (MRSA) in people who inject drugs (PWID): prevalence, risk factors and molecular epidemiology, Bristol, United Kingdom, 2012 to 2017.

Authors:  Simon Packer; Bruno Pichon; Stephen Thompson; Jane Neale; Jacquelyn Njoroge; Rachel M Kwiatkowska; Isabel Oliver; Maggie Telfer; Michel Doumith; Camillus Buunaaisie; Ellen Heinsbroek; Noreen Hopewell-Kelly; Monica Desai; Vivian Hope; Owen Martin Williams; Angela Kearns; Mathew Hickman; Maya Gobin
Journal:  Euro Surveill       Date:  2019-03

10.  Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study.

Authors:  Magdalena Harris; Jenny Scott; Talen Wright; Rachel Brathwaite; Daniel Ciccarone; Vivian Hope
Journal:  Harm Reduct J       Date:  2019-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.